血浆致动脉粥样硬化指数[log(甘油三酯/高密度脂蛋白胆固醇)]：理论与实际意义。 - Suppr

Suppr

超能文献

Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.

作者信息

Dobiásová Milada

出版信息

Clin Chem. 2004 Jul;50(7):1113-5. doi: 10.1373/clinchem.2004.033175.

DOI:10.1373/clinchem.2004.033175

PMID:15229146

Abstract

摘要

相似文献

Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.

Clin Chem. 2004 Jul;50(7):1113-5. doi: 10.1373/clinchem.2004.033175.

Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes.

Clin Chem. 2004 Jul;50(7):1184-8. doi: 10.1373/clinchem.2004.031757. Epub 2004 Apr 29.

The role of pioglitazone in modifying the atherogenic lipoprotein profile.

Diabetes Obes Metab. 2009 Aug;11(8):742-56. doi: 10.1111/j.1463-1326.2009.01048.x. Epub 2009 Jun 10.

Actos (pioglitazone): a new treatment for type 2 diabetes.

Hosp Med. 2001 Jul;62(7):411-6. doi: 10.12968/hosp.2001.62.7.1611.

[Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].

MMW Fortschr Med. 2007 Aug 2;149(31-32):52-3.

Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study.

Diabetes Care. 2003 Sep;26(9):2588-94. doi: 10.2337/diacare.26.9.2588.

Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study.

Diabetes Care. 2006 May;29(5):1016-23. doi: 10.2337/diacare.2951016.

Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.

J Am Coll Cardiol. 2011 Jan 11;57(2):153-9. doi: 10.1016/j.jacc.2010.06.055.

Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.

Diabetologia. 2005 Dec;48(12):2477-81. doi: 10.1007/s00125-005-0034-1. Epub 2005 Nov 10.

The clinical implications of the CHICAGO study for the management of cardiovascular risk in patients with type 2 diabetes mellitus.

Trends Cardiovasc Med. 2009 Apr;19(3):94-9. doi: 10.1016/j.tcm.2009.06.002.

引用本文的文献

The Association Between the Atherogenic Index of Plasma and Cognitive Function: Evidence From the NHANES 2011-2014.

Brain Behav. 2025 Aug;15(8):e70768. doi: 10.1002/brb3.70768.

Effect of Versus Simvastatin on the Skeletal Muscles of Experimentally Induced Dyslipidemia: A Multitarget Approach to Muscle Ultrastructural and Cytomolecular Modulation.

Med Sci (Basel). 2025 Aug 15;13(3):137. doi: 10.3390/medsci13030137.

The association between triglyceride-glucose index, atherogenic index of plasma, systemic immune-inflammation index, and mortality in patients with acute coronary syndrome: the direct effects of glucose-lipid metabolism and U-shaped immune modulation in mortality risk.

Front Cardiovasc Med. 2025 Jul 25;12:1604284. doi: 10.3389/fcvm.2025.1604284. eCollection 2025.

Association of non-traditional lipid indices with diabetes and insulin resistance in US adults: mediating effects of HOMA-IR and evidence from a national cohort.

Clin Exp Med. 2025 Aug 7;25(1):281. doi: 10.1007/s10238-025-01819-4.

Interaction of genetic risk score (GRS) and Plant-Based diet on atherogenic factors and body fat distribution indices among women with overweight and obesity: a cross-sectional study.

Sci Rep. 2025 Jul 8;15(1):24405. doi: 10.1038/s41598-025-09726-0.

Evaluation of Atherogenic Indexes in Patients With Lichen Planopilaris: A Case-Control Study.

Cureus. 2025 May 26;17(5):e84835. doi: 10.7759/cureus.84835. eCollection 2025 May.

Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes.

Sci Rep. 2025 May 5;15(1):15695. doi: 10.1038/s41598-025-01003-4.

Can the Atherogenic Index of Plasma (AIP) Be a Prognostic Marker for Good Clinical Outcome After Mechanical Thrombectomy for Acute Ischemic Stroke?

Diagnostics (Basel). 2025 Apr 8;15(8):947. doi: 10.3390/diagnostics15080947.

Association between the plasma atherogenic index and type 2 diabetes in Chinese population: prospective cohort study based on 4C study.

Front Endocrinol (Lausanne). 2025 Apr 16;16:1571602. doi: 10.3389/fendo.2025.1571602. eCollection 2025.

Effects of Six Months of Levothyroxine Therapy on Sympathovagal Imbalance and Cardiometabolic Profile in Overt Hypothyroid Patients.

Cureus. 2025 Mar 27;17(3):e81268. doi: 10.7759/cureus.81268. eCollection 2025 Mar.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验